ACE2 mRNA expression was compared between the two study groups, one-sample Wilcoxon signed ranks test also demonstrating significantly lower expression levels of ACE2 in COVID-19 patients compared to a hypothesized value (1.0) for controls. Here, ACE2 is linked to COVID-19.